Page last updated: 2024-11-06

acifluorfen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID44073
CHEMBL ID222440
CHEBI ID73172
SCHEMBL ID38929
MeSH IDM0069944

Synonyms (74)

Synonym
smr000471865
MLS001066351
benzoic acid, 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-
acifluorfen ,
5-{[2-chloro-4-(trifluoromethyl)phenyl]oxy}-2-nitrobenzoic acid
50594-66-6
ccris 3491
benzoic acid, 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitro-
5-(2-chloro-alpha,alpha,alpha-trifluoro-p-tolyloxy)-2-nitrobenzoic acid (iupac)
5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid
einecs 256-634-5
c14h7clf3no5
5-(2-chloro-4-trifluoromethylphenoxy)-2-nitrobenzoic acid
acifluorfene [iso-french]
brn 2953865
2-nitro-5-(2-chloro-4-(trifluoromethyl)phenoxy)benzoic acid
acifluorfen [bsi:iso]
acifluorfene
5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoate
5-(2-chloro-alapha,alpha,alpha-trifluoro-p-tolyloxy)-2-nitrobenzoic acid
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid
ACJ ,
carbofluorfen
blazer
tackle
NCGC00163887-02
NCGC00163887-01
NCGC00163887-03
DB07338
CHEMBL222440
chebi:73172 ,
FT-0639914
NCGC00163887-04
NCGC00163887-05
acifluorofen
NCGC00254664-01
dtxsid0020022 ,
cas-50594-66-6
NCGC00259388-01
dtxcid6022
tox21_300760
tox21_201839
A828196
5-[2-chloranyl-4-(trifluoromethyl)phenoxy]-2-nitro-benzoic acid
unii-oi60ib203a
oi60ib203a ,
bdbm50359942
AKOS015905368
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-benzoic acid
SCHEMBL38929
acifluorfen [mi]
acifluorfen (free acid)
acifluorfen [iso]
5-(2-chloro-4-trifluoromethylphenoxy)-2-nitro benzoic acid
5-(o-chloro-p-trifluoromethyl-phenoxy)-2-nitrobenzoic acid
2-nitro-5-(2-chloro-4-trifluoromethylphenoxy)benzoic acid
5-(2-chloro-4-trifluorometylphenoxy)-2-nitrobenzoic acid
5-(2-chloro-4-trifluoromethylphenoxy)-2-nitro-benzoic acid
rh-6201 (salt/mix)
blazer (salt/mix)
acifluorfen, pestanal(r), analytical standard
acifluorfen, analytical standard
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid, 9ci
(sodium salt) scifluorfen
tackle 25
5-(2-chloro-4-(trifluoromethyl)-phenoxy)-2-nitrobenzoic acid ,
mfcd00143541
Q2103461
AS-15230
C22041
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoicacid
CS-0095178
HY-128075
AKOS040758166

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Here, we present an improved statistical model to describe hormetic dose-response curves and test for the presence of hormesis."( Improved empirical models describing hormesis.
Cedergreen, N; Ritz, C; Streibig, JC, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
herbicideA substance used to destroy plant pests.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitorAn EC 1.3.3.* (oxidoreductase acting on donor CH-CH group with oxygen as acceptor) inhibitor that interferes with the action of protoporphyrinogen oxidase (EC 1.3.3.4).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
monocarboxylic acidAn oxoacid containing a single carboxy group.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (28)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency28.18380.004023.8416100.0000AID485290
SMAD family member 2Homo sapiens (human)Potency44.17020.173734.304761.8120AID1346859; AID1346924
SMAD family member 3Homo sapiens (human)Potency44.17020.173734.304761.8120AID1346859; AID1346924
AR proteinHomo sapiens (human)Potency33.00470.000221.22318,912.5098AID743035; AID743036; AID743053; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency65.42200.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency57.06980.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency45.93110.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency35.12760.000214.376460.0339AID588532; AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency0.24460.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency44.26960.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency68.93850.001530.607315,848.9004AID1224841
farnesoid X nuclear receptorHomo sapiens (human)Potency4.36200.375827.485161.6524AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency61.44150.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency29.10070.000229.305416,493.5996AID743069; AID743075; AID743078; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency36.07580.001024.504861.6448AID588534; AID588535; AID743212; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency55.25790.001019.414170.9645AID743094; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency43.86020.023723.228263.5986AID743222
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency44.25670.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency34.839419.739145.978464.9432AID1159509
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency89.12510.354828.065989.1251AID504847
chromobox protein homolog 1Homo sapiens (human)Potency63.09570.006026.168889.1251AID540317
importin subunit beta-1 isoform 1Homo sapiens (human)Potency100.00005.804836.130665.1308AID540263
snurportin-1Homo sapiens (human)Potency100.00005.804836.130665.1308AID540263
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency27.27830.000627.21521,122.0200AID743202
gemininHomo sapiens (human)Potency0.11760.004611.374133.4983AID624296; AID624297
DNA polymerase kappa isoform 1Homo sapiens (human)Potency26.67950.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Protoporphyrinogen oxidase, mitochondrialNicotiana tabacum (common tobacco)Ki0.07000.07000.07000.0700AID633803
Protoporphyrinogen oxidaseHomo sapiens (human)Ki1.71000.72001.36092.9300AID633804
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
porphyrin-containing compound biosynthetic processProtoporphyrinogen oxidaseHomo sapiens (human)
protoporphyrinogen IX biosynthetic processProtoporphyrinogen oxidaseHomo sapiens (human)
heme biosynthetic processProtoporphyrinogen oxidaseHomo sapiens (human)
heme A biosynthetic processProtoporphyrinogen oxidaseHomo sapiens (human)
heme B biosynthetic processProtoporphyrinogen oxidaseHomo sapiens (human)
heme O biosynthetic processProtoporphyrinogen oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
oxygen-dependent protoporphyrinogen oxidase activityProtoporphyrinogen oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingProtoporphyrinogen oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
mitochondrial inner membraneProtoporphyrinogen oxidaseHomo sapiens (human)
mitochondrial intermembrane spaceProtoporphyrinogen oxidaseHomo sapiens (human)
mitochondrial membraneProtoporphyrinogen oxidaseHomo sapiens (human)
mitochondrial inner membraneProtoporphyrinogen oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID278576Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID1082518Herbicidal activity against Abutilon theophrasti (velvetleaf) at 1000 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082516Herbicidal activity against Abutilon theophrasti (velvetleaf) at 40 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082506Herbicidal activity against Portulaca oleracea at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082511Herbicidal activity against Abutilon theophrasti (velvetleaf) at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082504Herbicidal activity against Amaranthus retroflexus at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082526Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) at 40 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082517Herbicidal activity against Abutilon theophrasti (velvetleaf) at 200 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID633803Inhibition of Nicotiana tobacum PPO2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Quantitative structure-activity relationships of 1,3,4-thiadiazol-2(3H)-ones and 1,3,4-oxadiazol-2(3H)-ones as human protoporphyrinogen oxidase inhibitors.
AID1082533Herbicidal activity against Echinochloa crus-galli (barnyard grass) at 40 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082497Herbicidal activity against Xanthium strumarium (cocklebur) at 100 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082489Toxicity against Triticum aestivum (wheat) at 100 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082536Herbicidal activity against Echinochloa crus-galli (barnyard grass) at 1000 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082495Herbicidal activity against Abutilon theophrasti (velvetleaf) at postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082490Toxicity against Glycine max (soybean) at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID633804Inhibition of human PPO expressed in Escherichia coli BL21(DE3) by continuous fluorometric method2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Quantitative structure-activity relationships of 1,3,4-thiadiazol-2(3H)-ones and 1,3,4-oxadiazol-2(3H)-ones as human protoporphyrinogen oxidase inhibitors.
AID1082525Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) at 200 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082494Toxicity against Glycine max (soybean) at postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082486Crop selectivity index, ratio of LD10 for soybean to LD90 for velvetleaf2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082492Toxicity against Glycine max (soybean) at 100 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID278577Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID1082527Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) at 1000 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082484Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) at 100 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082519Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082485Herbicidal activity against Echinochloa crus-galli (barnyard grass) at 100 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082483Herbicidal activity against Abutilon theophrasti (velvetleaf) at 100 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082530Herbicidal activity against Echinochloa crus-galli (barnyard grass) at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082488Toxicity against Triticum aestivum (wheat) at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082508Herbicidal activity against Cenchrus americanus at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082535Herbicidal activity against Echinochloa crus-galli (barnyard grass) at 200 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082502Herbicidal activity against Commelina communis (Asiatic dayflower) at 400 g/hm2 post-emergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082500Herbicidal activity against Commelina communis (Asiatic dayflower) at 100 g/hm2 post-emergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082498Herbicidal activity against Xanthium strumarium (cocklebur) at 400 g/hm2 postemergent application after 2 weeks2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
AID1082487Inhibition of protoporphyrinogen IX oxidase2011Journal of agricultural and food chemistry, Nov-09, Volume: 59, Issue:21
Synthesis and herbicidal activity of diphenyl ether derivatives containing unsaturated carboxylates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (8.33)18.7374
1990's16 (26.67)18.2507
2000's19 (31.67)29.6817
2010's14 (23.33)24.3611
2020's6 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.92 (24.57)
Research Supply Index4.19 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index56.96 (26.88)
Search Engine Supply Index2.21 (0.95)

This Compound (37.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical Evaluation of the Blazer® Open-Irrigated Radiofrequency Ablation Catheter for the Treatment of Type 1 Atrial Flutter [NCT01253200]302 participants (Actual)Interventional2011-01-31Completed
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation [NCT01687166]398 participants (Actual)Interventional2012-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT01253200 (4) [back to overview]Acute Success Rate
NCT01253200 (4) [back to overview]Chronic Success Rate: Acute Success Patients
NCT01253200 (4) [back to overview]Chronic Success Rate: All Treated Patients
NCT01253200 (4) [back to overview]Procedure-related Complication-free Rate
NCT01687166 (3) [back to overview]Acute Success
NCT01687166 (3) [back to overview]Chronic Success Rate
NCT01687166 (3) [back to overview]Procedure-related Complication Free Rate

Acute Success Rate

Acute success is defined as demonstration of bidirectional cavo-tricuspid isthmus block (ie, lack of electrophysiological conduction through the isthmus) 30 minutes after the last radiofrequency application in the cavo-tricuspid isthmus with the investigational or control catheter only. (NCT01253200)
Timeframe: 30 minutes after the last radiofrequency application in the cavo-tricuspid isthmus

Interventionpercentage of success (Number)
Blazer® Open-Irrigated Ablation Catheter87.2
Control Catheter89.2

[back to top]

Chronic Success Rate: Acute Success Patients

Chronic success is defined as demonstration of acute success and freedom from recurrence of type 1 atrial flutter at 3-months post-procedure. Only randomized patients with acute procedural success will be included in this endpoint. (NCT01253200)
Timeframe: 3-months post-procedure

Interventionpercentage of chronic success (Number)
Blazer® Open-Irrigated Ablation Catheter85.3
Control Catheter89.9

[back to top]

Chronic Success Rate: All Treated Patients

Chronic success is defined as freedom from recurrence of type 1 atrial flutter at 3-months post-procedure for all treated patients. (NCT01253200)
Timeframe: 3 months post-procedure

Interventionpercentage of subjects (Number)
Blazer® Open-Irrigated Ablation Catheter74.3
Control Catheter80.2

[back to top] [back to top]

Acute Success

Demonstration that the investigational group acute procedural success rate is non-inferior to that of the control group. Acute procedural success is defined as a subject that successfully had all clinically relevant veins electrically isolated, by demonstration of entrance block at a minimum and no evidence of exit conduction with the randomized investigational or control catheter only. (NCT01687166)
Timeframe: Acute- During Index Procedure, 20 minutes after confirmation of Pulmonary Vein Isolation

InterventionParticipants (Count of Participants)
Blazer Open-Irrigated Ablation Catheter155
Control163

[back to top]

Chronic Success Rate

"The primary effectiveness of the Blazer OI catheter will be evaluated by demonstrating that the proportion of subjects free from failure* in the investigational group is non-inferior to those in the control group.~*failure is defined as a randomized subject being an acute procedural failure, having more than one repeat procedure during the 90 day blanking period or having a documented symptomatic atrial fibrillation, atrial tachycardia, atrial fibrillation between 91 days and 12 months post-procedure." (NCT01687166)
Timeframe: Within 12 months of the index procedure

InterventionParticipants (Count of Participants)
Blazer Open-Irrigated Ablation Catheter102
Control108

[back to top] [back to top]